Introduction:

Pharmaceutical excipients are substances other than an active pharmaceutical ingredient contained in a drug delivery system. Pharmaceutical excipients are inactive substances contributing to lubricity, fluidity, disintegration, taste and can impart some form of antimicrobial function. Pharmaceutical excipients are used to simplify the manufacture of pharmaceutical products and help to promote the physiological absorption of the drug. These are also used to protect, support, or enhance stability of the formulation. Pharmaceutical excipients are substances other than the active pharmaceutical ingredient (API) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. Simply said the excipients enable the drug substance to be applied to the patient in the right form and supports the way and place of action without being active themselves.Pharmaceutical Excipients Market accounted for US$ 6.52 billion 2020 and is estimated to be US$ 10.49 billion by 2030 and is anticipated to register a CAGR of 5.3%.

Excipients provide better functionality

Excipients provide better functionality such as longer shelf life of formulations, which is a major factor driving the pharmaceutical excipients market. For instance, According to data published by Centers for Disease Control and Prevention, in 2018, that vaccines contains excipients with their role such as preservatives to prevent contamination for example, thimerosal, adjuvants help to stimulate a stronger immune response for example, aluminum salts, stabilizers keep the vaccine potent during transportation and storage for example, sugars or gelatin. In addition, rising demand for generic medicine across the globe is factor driving the growth of the pharmaceutical excipients market. For instance, according to data published by International Trade Administration, in 2016, in the United States, upon either patent expiration or a successful challenge of relevant patents, a manufacturer can produce a generic drug as long as it meets FDA approval and bioequivalence standards.

List of patent expired blockbuster drugs

In addition, list of patent expired blockbuster drugs in 2018 are expected to promote the pharmaceutical excipients market over the forecast period. For instance, Lyrica (pregabalin) for fibromyalgia and neuropathic pain manufactured by Pfizer Inc patent expired in December 2018. Multifunctional excipients are proving to be emerging areas of new product development which is expected to create lucrative growth opportunity for the major players operating in the pharmaceutical excipients market.

However, cost-efficiency and time consuming process of drug development are hindering the target market.

This report segments the pharmaceutical excipients market on the basis of product, functionality, formulation, and region. On the basis of product, the target market is segmented into organic chemicals and inorganic chemicals. The organic chemical is segment accounted for major share in the pharmaceutical excipients market. This is owing to this organic chemicals increases efficiency regarding poorly soluble orally delivered molecules. On the basis of functionality, the pharmaceutical excipients market is categorized into fillers and diluents, binders, disintegrants, lubricants and glidants, and others. Others functionality sub-segment is bifurcated into coating agents, preservatives, emulsifying agents, and flavoring agents and sweeteners. On the basis of formulation, the target market is divided into oral formulations, topical formulations, parenteral formulations, and others. Others formulation sub-segment is classified into vaginal inhaled, ophthalmic, and optic.

Key features of the study:

Prophecy Market Insights provides detailed analysis on pharmaceutical excipients market in our report- Pharmaceutical Excipients Market by product, by functionality, by formulation, and region The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the pharmaceutical excipients market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices includes in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the pharmaceutical excipients market.

For detailed understanding of market dynamics, the pharmaceutical excipients market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the pharmaceutical excipients market. The Europe pharmaceutical excipients market is expected to dominate the  pharmaceutical excipients market over the forecast period. This is owing to presence of European Medicines Agency’s scientific guidelines on excipients, which facilitates pharmaceutical entities to prepare marketing authorization applications for medicines for human consumption in the European countries. The North America pharmaceutical excipients market is expected to account for second-highest share in terms of revenue in the near future. This is due to increasing demand for generic drugs and over-the-counter drugs in countries such as U.S. of the North America region. For instance, according to data published by International Trade Administration, in 2016, In the United States, there are an estimated 100,000 over-the-counter drugs drug products marketed and sold in a variety of outlets, such as pharmacies and convenience stores. The Asia Pacific pharmaceutical excipients market is expected to account for fastest growth rate in the global pharmaceutical excipients market over the forecast period. This can be attributed to growing penetration of generic drugs which in turn increases penetration of pharmaceutical ingredients in the countries such as India and China of the region.

Pharmaceutical Excipients Market, By Product:

• Organic chemicals
  • Inorganic chemicals

Pharmaceutical Excipients Market, By Functionality:

• Fillers and diluents
  • Others (coating agents, preservatives, emulsifying agents, and flavoring agents and sweeteners)
  • Lubricants and glidants
  • Disintegrants
  • Binders

Pharmaceutical Excipients Market, By Formulation:

• Oral formulations
  • Others (vaginal, inhaled, ophthalmic, and optic)
  • Parenteral formulations
  • Topical formulations

Pharmaceutical Excipients Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Pharmaceutical Excipients Market, By Product
    • Middle East & Africa Pharmaceutical Excipients Market, By Functionality
    • Middle East & Africa Pharmaceutical Excipients Market, By Formulation
    • Middle East & Africa Pharmaceutical Excipients Market, By Country
      • GCC
      • Israel
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Pharmaceutical Excipients Market, By Product
    • Latin America Pharmaceutical Excipients Market, By Functionality
    • Latin America Pharmaceutical Excipients Market, By Formulation
    • Latin America Pharmaceutical Excipients Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia-Pacific
    • Asia-Pacific Pharmaceutical Excipients Market, By Product
    • Asia-Pacific Pharmaceutical Excipients Market, By Functionality
    • Asia-Pacific Pharmaceutical Excipients Market, By Formulation
    • Asia-Pacific Pharmaceutical Excipients Market, By Country
      • China
      • India
      • Australia
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Pharmaceutical Excipients Market, By Product
    • Europe Pharmaceutical Excipients Market, By Functionality
    • Europe Pharmaceutical Excipients Market, By Formulation
    • Europe Pharmaceutical Excipients Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Pharmaceutical Excipients Market, By Product
  • North America Pharmaceutical Excipients Market, By Functionality
  • North America Pharmaceutical Excipients Market, By Formulation
  • North America Pharmaceutical Excipients Market, By Country
    • U.S.
    • Canada

Some of the prominent players operating in the pharmaceutical excipients market include Eastman Chemical Company, The Procter & Gamble Manufacturing Company, Merck & Co., Inc., Avantor Performance Materials, LLC, Huntsman Corporation, ABITEC Corporation, BASF SE, Ashland Global Holdings Inc, FMC Corporation, and Colorcon, Inc. Technological advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the pharmaceutical excipients market. For instance, in December 2016, Merck & Co., Inc launched ParteckXP which is a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active. Further, on February 5, 2019, ABITEC Corporation launched CAPMUL GDB EP/NF. This is high-purity, highly-reproducible solid lipid exipient which offers good flow and uniform particle size distribution for use in multiple formulations, including tablets, hard gels, softgels, solid lipid nanoparticles, nano-structured lipids, granulations, multi-particulates, extrudates, congealing, and liquids.

ABITEC Corporation

ABITEC is a world leader in the manufacturing and production of specialised lipids and surfactants. They provide the finest quality solutions in solubilization, emulsification, and lubrication due to their exceptional technical, scientific, regulatory, and production competence. The ABITEC Corporation is committed to advancing critical formulation development and bioavailability enhancement technology. For the pharmaceutical sector, ABITEC produce lipid-based excipients to improve the bioavailability of compounds that are poorly water soluble and permeable. Their superior lipid excipients for drug delivery applications adhere to IPEC (International Pharmaceutical Excipient Council) standards and strict cGMP regulations. They are monograph compliant and of the highest quality.

• Eastman Chemical Company
  • FMC Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Colorcon, Inc. Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Ashland Global Holdings Inc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • BASF SE
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • ABITEC Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Huntsman Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Avantor Performance Materials, LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Merck & Co., Inc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • The Procter & Gamble Manufacturing Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Preview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product
     • Market Snippet, By Functionality
     • Market Snippet, By Formulation
     • Market Snippet, By Region
   • Opportunity Map Analysis
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Market Trends
   • Product Launch
   • Impact Analysis
   • PEST Analysis
   • Porter’s Analysis
4. Market Segmentation, By Product, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Organic Chemicals
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Inorganic Chemicals
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
5. Market Segmentation, By Functionality, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Fillers and Diluents
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Binders
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Disintegrants
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Lubricants and Glidants
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Others (Coating Agents, Preservatives, Emulsifying Agents, and Flavoring Agents and Sweeteners)
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
6. Market Segmentation, By Formulation, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Segment Trends
   • Oral Formulations
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Topical Formulations
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Parenteral Formulations
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
   • Others (Vaginal, Inhaled, Ophthalmic, and Optic)
     • Overview
     • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
7. Global Market, By Region, 2019 – 2029, (US$ Bn)
   • Overview
     • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
     • Y-o-Y Growth Analysis (%), 2019 – 2029
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • Germany
       • UK
       • France
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • China
       • India
       • Australia
       • Japan
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast (US$ Bn), By Product, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Functionality, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Formulation, 2019 – 2029
     • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
       • South Africa
       • Central Africa
       • North Africa
8. Competitive Landscape
   • Heat Map Analysis
   • Company Profiles
     • Eastman Chemical Company
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • The Procter & Gamble Manufacturing Company
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Merck & Co., Inc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Avantor Performance Materials, LLC
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Huntsman Corporation
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • ABITEC Corporation
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • BASF SE
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Ashland Global Holdings Inc
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • FMC Corporation
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Colorcon, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
     • Roquette Frères S.A
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
   • Analyst Views
9. Section
   • Research Methodology
   • About Us
   • Contact